AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2017
Aug 9, 2017
32853_dirs_2017-08-08_74a83014-9956-46e3-9d2f-80dea045a8e9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: FLUIDIGM CORP (FLDM)
CIK: 0001162194
Period of Report: 2017-08-08
Reporting Person: McPhail Steven (Chief Commercial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-08-08 | Common Stock | P | 20000 | $3.0016 | Acquired | 27842 | Direct |
Footnotes
F1: The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares purchased. These shares were purchased in multiple transactions at prices ranging from $2.65 to $3.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
More from STANDARD BIOTOOLS INC.
M&A Activity
2026
Jun 8
M&A Activity
2026
Jun 8
Regulatory Filings
2026
Jun 5
Board/Management Information
2026
Jun 3
Regulatory Filings
2026
May 29
Board/Management Information
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3